跳至主要内容
临床试验/NCT01505959
NCT01505959Unknown4 期

Blood Pressure Reduction Induced by Continuous Positive Airway Pressure (CPAP) in Sleep Apnea Patients at High Cardiovascular Risk : A Randomized Controlled Trial Comparing Usual CPAP Care Versus a Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform

Fédération Française de Pneumologie44 个研究点 分布在 1 个国家目标入组 936 人开始时间: 2013年2月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
936
试验地点
44
主要终点
Systolic blood pressure evolution by comparing baseline and 6 months measurements

研究概览

简要总结

Targeted population:

Sleep apnea patients at high cardiovascular risk newly treated by CPAP

Hypothesis:

Improvement in blood pressure after 6 months of CPAP treatment might be greater in the telemonitoring arm compared to usual CPAP care.

Main goal:

To compare 6-months blood pressure reduction when Sleep Apnea patients at high cardiovascular risk are randomly allocated to usual CPAP care or a multidisciplinary and coordinated follow-up based on a telemonitoring web platform.

详细描述

Study procedures:

The telemonitoring system will involve respiratory physicians, home care providers and include regular assessments of home self-measured blood pressure, oximetry, physical activity recorded by actigraphy, CPAP compliance, side effects and residual events.

Secured data transmission to medical staff computers and secured websites will allow easy telemonitoring. Automatic algorithms have been built-up for early adjustment of CPAP treatment in case of side effects, leaks and persistent residual events.

An interim analysis will be performed when 300 patients will be included.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 78 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18 to 78 years
  • Men and women
  • AHI > 30 / hour
  • Patient with high cardiovascular score (>5% defined by European SCORE) or known cardiovascular disease (i.e. transient ischemic attack, stroke, coronary artery disease)
  • Patient affiliated to the National health insurance
  • Willingness to use a telemonitoring system

排除标准

  • Central sleep apnea syndrome
  • Previous CPAP treatment with respiratory support for sleep respiratory trouble
  • Cardiac failure with left ventricular ejection fraction lesser than 40%
  • Hypercapnic chronic respiratory failure (daytime PaCO2 > 50 mmHg)
  • Terminal disease

结局指标

主要结局

Systolic blood pressure evolution by comparing baseline and 6 months measurements

时间窗: day 0 and month 6

Systolic blood pressure is assessed at day 0 and month 6 in the two groups by home self-measured blood pressure (4 consecutive days)

次要结局

  • Subjective Sleepiness(inclusion and month 6)
  • Health status(inclusion and month 6)
  • Objective CPAP compliance at 6 months(day 0 and month 6)
  • Fatigue(inclusion and month 6)
  • Quality of Life(inclusion and month 6)
  • Diastolic blood pressure evolution by comparing baseline and 6 months(day 0 and month 6)
  • Physical activity(inclusion and month 6)
  • Cost analysis(month 6)

研究者

发起方
Fédération Française de Pneumologie
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean Louis PEPIN

Professor, PhD, Hospital Grenoble France

Fédération Française de Pneumologie

研究点 (44)

Loading locations...

相似试验